Is A Class-Wide Myocarditis Warning Coming For COVID-19 Vaccines?

 
• By Derrick Gingery

Now that multiple vaccines using different platforms seem to be associated with heart inflammation, the FDA and others want more data on whether a common characteristic of the virus or vaccine manufacturing is related.

Heart and COVID-19
The FDA is wondering whether myocarditis is a class-wide adverse event for COVID-19 vaccines. • Source: Shutterstock

More from Vaccines

More from Pink Sheet